Skip to content
10-Q

Quarterly Report

OncoMed Pharmaceuticals Inc

0001564590-18-018695

← back to feed
Filed
Aug 2, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 1, 2018 38.5M sh
Capex Q2 2018 · Jun 30, 2018 $283K
Capex Q2 2018 · Jun 30, 2017 $464K
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$22.64M
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$56.09M
Short Term Investments Q2 2018 · Jun 30, 2018 $69.31M
Short Term Investments Q2 2018 · Dec 31, 2017 $89.81M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $10.56M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $13.28M
Cash And Equivalents Q2 2018 · Jun 30, 2017 $31.94M
Cash And Equivalents Q2 2018 · Dec 31, 2016 $36.95M
Stockholders Equity Q2 2018 · Jun 30, 2018 $43.98M
Stockholders Equity Q2 2018 · Dec 31, 2017 −$48.6M
Current Liabilities Q2 2018 · Jun 30, 2018 $33.23M
Current Liabilities Q2 2018 · Dec 31, 2017 $93.13M
Total Liabilities Q2 2018 · Jun 30, 2018 $41.93M
Total Liabilities Q2 2018 · Dec 31, 2017 $158.93M
Current Assets Q2 2018 · Jun 30, 2018 $81.47M
Current Assets Q2 2018 · Dec 31, 2017 $105.21M
Total Assets Q2 2018 · Jun 30, 2018 $85.91M
Total Assets Q2 2018 · Dec 31, 2017 $110.32M
Sga Expense Q2 2018 · Jun 30, 2018 $3.7M
Sga Expense Q2 2018 · Jun 30, 2018 $9.1M
Sga Expense Q2 2018 · Jun 30, 2017 $4.1M
Sga Expense Q2 2018 · Jun 30, 2017 $9.08M
Rd Expense Q2 2018 · Jun 30, 2018 $8.05M
Rd Expense Q2 2018 · Jun 30, 2018 $16.44M
Rd Expense Q2 2018 · Jun 30, 2017 $15.09M
Rd Expense Q2 2018 · Jun 30, 2017 $39.08M
Net Income Q2 2018 · Jun 30, 2018 −$3.98M
Net Income Q2 2018 · Jun 30, 2018 −$9.55M
Net Income Q2 2018 · Jun 30, 2017 −$15.23M
Net Income Q2 2018 · Jun 30, 2017 −$37.83M
Operating Income Q2 2018 · Jun 30, 2018 −$4.89M
Operating Income Q2 2018 · Jun 30, 2018 −$10.82M
Operating Income Q2 2018 · Jun 30, 2017 −$15.44M
Operating Income Q2 2018 · Jun 30, 2017 −$38.19M